ReviewPharmaceutics2021
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.
Stephen Ahenkorah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
56 papers cite it
this papercites it
ReviewPharmaceutics2021
Stephen Ahenkorah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.